Predictors for long-term survival free from whole brain radiation therapy in patients treated with radiosurgery for limited brain metastases

by Daniel eGorovets, Daniel eGorovets, Paul eRava, Daniel K Ebner, David J Tybor, Deus eCielo, Yakub ePuthawala, Timothy J Kinsella, Thomas A DiPetrillo, Thomas A DiPetrillo, David E Wazer, David E Wazer, Jaroslaw T Hepel, Jaroslaw T Hepel
Published 2015-05-01

Dosimetric Feasibility of Dose Escalation Using SBRT Boost for Stage III Non-Small Cell Lung Cancer

by Jaroslaw T. Hepel, Justin ePeter, Jessica R. Hiatt, Salil ePatel, Oluwademilade eOsibanjo, Howard eSafran, Bruce eCurran, Thomas eDiPetrillo
Published 2012-09-01

Local failure and vertebral body fracture risk using multifraction stereotactic body radiation therapy for spine metastases

by Nihaal Mehta, BA, Peter J. Zavitsanos, MD, Krisztina Moldovan, MD, Adetokunbo Oyelese, MD, PhD, Jared S. Fridley, MD, Ziya Gokaslan, MD, Timothy J. Kinsella, MD, Jaroslaw T. Hepel, MD
Published 2018-07-01

Management approach for recurrent brain metastases following upfront radiosurgery may affect risk of subsequent radiation necrosis

by Ali Rae, BS, Daniel Gorovets, MD, Paul Rava, MD PhD, Daniel Ebner, BS, Deus Cielo, MD, Timothy J. Kinsella, MD, Thomas A. DiPetrillo, MD, Jaroslaw T. Hepel, MD
Published 2016-10-01